Drugs / NmVac4-A/C/Y/W-135-DT™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01897402 | Jul 2013 → May 2014 | meningococcal meningitis | JN-International Medical Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NmVac4-A/C/Y/W-135-DT | “NmVac4-A/C/Y/W-135-DT™ conjugate is a vaccine in liquid form composed of purified polysaccharides (PS) conjugated to diphtheria toxoid.” NCT01897402 ↗ |
| Modality | Vaccine | “is a vaccine” NCT01897402 ↗ |
| Route | Intramuscular | “Single intramuscular 0.5 mL dose” NCT01897402 ↗ |